You are here

Article Text

Article menu
Download PDFPDF
Editorial
Meeting QOF hypertension targets but failing the patient
  1. James A Cave, Editor-in-Chief
  1. DTB, BMJ Journals, London, UK
  1. Correspondence to Dr James A Cave, The Downland Practice, Berkshire RG20 8UY, UK; jcave{at}bmj.com

https://doi.org/10.1136/dtb.2019.000048

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The National Institute for Health and Care Excellence (NICE) guideline for the management of hypertension has attracted considerable attention for its tightening of treatment thresholds and targets. Of particular interest is its recommendation to offer antihypertensive drug treatment to adults under the age of 80 years who have persistent stage 1 hypertension and an estimated 10-year risk of cardiovascular disease of 10% or more.1 Antihypertensive drug treatment should also be considered for those aged over 80 years with a clinic blood pressure of over 150/90 mm Hg. Perhaps of greater significance are the changes to the hypertension indicator in the Quality and Outcomes Framework (QOF) for primary care in England.2 The thresholds for payment are 40%–77% for achieving a blood pressure of 140/90 mm Hg or lower in patients aged below 80 years, …

    View Full Text

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; externally peer reviewed.